Other Pharmaceuticals - Nepal

  • Nepal
  • The Other Pharmaceuticals market in Nepal is anticipated to witness a significant increase in revenue, with projections indicating a rise to NPR US$76.86m by 2024.
  • This growth is further expected to continue at a steady pace, with an annual growth rate (CAGR 2024-2029) of 4.70%.
  • Consequently, the market volume is forecasted to reach NPR US$96.72m by 2029.
  • In a global context, it is worth noting that United States will dominate this market, generating a substantial amount of revenue.
  • The projected revenue for the United States in 2024 is estimated at US$260.50bn.
  • In Nepal, the market for other pharmaceuticals is experiencing a surge in demand due to the country's growing population and increasing health consciousness.

Key regions: China, Europe, Australia, United States, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Pharmaceuticals market in Nepal has been experiencing significant growth in recent years.

Customer preferences:
Nepal has a growing population with an increasing demand for healthcare services, including pharmaceuticals. Due to the lack of a well-established healthcare system, Nepalese consumers tend to rely heavily on pharmacies for their healthcare needs. As a result, the demand for Other Pharmaceuticals has been on the rise.

Trends in the market:
One of the major trends in the Other Pharmaceuticals market in Nepal is the increasing use of generic drugs. Due to the high cost of branded drugs, Nepalese consumers have been turning to generic drugs as a more affordable alternative. The government of Nepal has also been promoting the use of generic drugs as part of its efforts to make healthcare more accessible and affordable to its citizens.Another trend in the market is the growing popularity of traditional medicines. Many Nepalese consumers prefer traditional medicines over modern drugs due to cultural and religious beliefs. Traditional medicines are also perceived to be more natural and less harmful than modern drugs.

Local special circumstances:
Nepal is a landlocked country with a challenging terrain, which makes it difficult to transport pharmaceuticals to remote areas. As a result, the distribution of pharmaceuticals in Nepal is often limited to urban areas. However, the government of Nepal has been working to improve the distribution of pharmaceuticals to remote areas through various initiatives such as the establishment of mobile health clinics.

Underlying macroeconomic factors:
Nepal is one of the poorest countries in the world with a low GDP per capita. The high cost of branded drugs makes them unaffordable for most Nepalese consumers. The government of Nepal has been working to make healthcare more accessible and affordable to its citizens through various initiatives such as the provision of free healthcare services to low-income families.In conclusion, the Other Pharmaceuticals market in Nepal is experiencing significant growth due to the increasing demand for healthcare services, the growing popularity of generic drugs, and the preference for traditional medicines. However, the distribution of pharmaceuticals in remote areas remains a challenge, and the high cost of branded drugs makes them unaffordable for most Nepalese consumers.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)